{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:13:23Z","timestamp":1778717603910,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":38,"publisher":"Springer US","isbn-type":[{"value":"9781071650400","type":"print"},{"value":"9781071650417","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5041-7_21","type":"book-chapter","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:40:37Z","timestamp":1778715637000},"page":"439-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Generation and Characterization of CAR-T Cells"],"prefix":"10.1007","author":[{"given":"Sarah","family":"Ash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greta Maria Paola Giordano","family":"Attianese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paris","family":"Kosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aikaterini","family":"Semilietof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Stefanidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Triboulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melita","family":"Irving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fimmu.2017.00267","volume":"8","author":"M Irving","year":"2017","unstructured":"Irving M, Vuillefroy de Silly R, Scholten K, Dilek N, Coukos G (2017) Engineering chimeric antigen receptor T cells for racing in solid tumors: don't forget the fuel. Front Immunol 8:267","journal-title":"Front Immunol"},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ymthe.2017.12.001","volume":"26","author":"A Capsomidis","year":"2018","unstructured":"Capsomidis A, Benthall G, Van Acker HH, Fisher J, Kramer AM, Abeln Z, Majani Y, Gileadi T, Wallace R, Gustafsson K, Flutter B, Anderson J (2018) Chimeric antigen receptor-engineered human gamma delta T cells: enhanced cytotoxicity with retention of cross presentation. Mol Ther 26:354\u2013365","journal-title":"Mol Ther"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky M, Ruella M, Shestova O, Lu\u00a0XM, Best\u00a0A, Zeeman M, Schmierer M, Gabrusiewicz\u00a0K, Anderson NR, Petty NE, Cummins KD, Shen F, Shan X, Veliz K, Blouch\u00a0K, Yashiro-Ohtani Y, Kenderian SS, Kim\u00a0MY, O'Connor RS, Wallace SR, Kozlowski\u00a0MS, Marchione DM, Shestov M, Garcia BA, June CH, Gill S (2020) Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol 38:947\u2013953","journal-title":"Nat Biotechnol"},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","volume":"30","author":"D Marin","year":"2024","unstructured":"Marin D, Li Y, Basar R, Rafei H, Daher\u00a0M, Dou\u00a0J, Mohanty V, Dede M, Nieto Y, Uprety\u00a0N, Acharya S, Liu E, Wilson J, Banerjee P, Macapinlac HA, Ganesh C, Thall PF, Bassett R, Ammari M, Rao S, Cao K, Shanley M, Kaplan M, Hosing C, Kebriaei P, Nastoupil LJ, Flowers CR, Moseley SM, Lin P, Ang S, Popat UR, Qazilbash MH, Champlin RE, Chen K, Shpall EJ, Rezvani K (2024) Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19(+) B cell tumors: a phase 1\/2 trial. Nat Med 30:772\u2013784","journal-title":"Nat Med"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41586-023-05778-2","volume":"615","author":"AM Tousley","year":"2023","unstructured":"Tousley AM, Rotiroti MC, Labanieh L, Rysavy LW, Kim WJ, Lareau C, Sotillo E, Weber EW, Rietberg SP, Dalton GN, Yin Y, Klysz D, Xu P, de la Serna EL, Dunn AR, Satpathy AT, Mackall CL, Majzner RG (2023) Co-opting signalling molecules enables logic-gated control of CAR-T cells. Nature 615:507\u2013516","journal-title":"Nature"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"eadp8569","DOI":"10.1126\/scisignal.adp8569","volume":"17","author":"L Balagopalan","year":"2024","unstructured":"Balagopalan L, Moreno T, Qin H, Angeles BC, Kondo T, Yi J, McIntire KM, Alvinez N, Pallikkuth S, Lee ME, Yamane H, Tran AD, Youkharibache P, Cachau RE, Taylor N, Samelson LE (2024) Generation of antitumor chimeric antigen receptors incorporating T cell signaling motifs. Sci Signal 17:eadp8569","journal-title":"Sci Signal"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/imr.13252","volume":"320","author":"GMP Giordano Attianese","year":"2023","unstructured":"Giordano Attianese GMP, Ash S, Irving M (2023) Coengineering specificity, safety, and function into T cells for cancer immunotherapy. Immunol Rev 320:166\u2013198","journal-title":"Immunol Rev"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41587-019-0403-9","volume":"38","author":"G Giordano-Attianese","year":"2020","unstructured":"Giordano-Attianese G, Gainza P, Gray-Gaillard E, Cribioli E, Shui S, Kim S, Kwak MJ, Vollers S, Corria Osorio AJ, Reichenbach P, Bonet J, Oh BH, Irving M, Coukos G, Correia BE (2020) A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T cell therapy. Nat Biotechnol 38:426\u2013432","journal-title":"Nat Biotechnol"},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.cell.2022.03.041","volume":"185","author":"L Labanieh","year":"2022","unstructured":"Labanieh L, Majzner RG, Klysz D, Sotillo E, Fisher CJ, Vilches-Moure JG, Pacheco KZB, Malipatlolla M, Xu P, Hui JH, Murty T, Theruvath J, Mehta N, Yamada-Hunter SA, Weber EW, Heitzeneder S, Parker KR, Satpathy AT, Chang HY, Lin MZ, Cochran JR, Mackall CL (2022) Enhanced safety and efficacy of protease-regulated CAR-T cell receptors. Cell 185:1745\u20131763","journal-title":"Cell"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"aab4077","DOI":"10.1126\/science.aab4077","volume":"350","author":"CY Wu","year":"2015","unstructured":"Wu CY, Roybal KT, Puchner EM, Onuffer J, Lim WA (2015) Remote control of therapeutic T cells through a small molecule-gated chimeric receptor. Science 350:aab4077","journal-title":"Science"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ccell.2022.08.008","volume":"40","author":"HS Li","year":"2022","unstructured":"Li HS, Wong NM, Tague E, Ngo JT, Khalil AS, Wong WW (2022) High-performance multiplex drug-gated CAR circuits. Cancer Cell 40:1294\u20131305","journal-title":"Cancer Cell"},{"key":"21_CR12","first-page":"2008.2006.60645","volume":"2024","author":"L Scheller","year":"2024","unstructured":"Scheller L, Attianese GMPG, Castellanos-Rueda R, Di Roberto RB, Barden M, Triboulet M, Shui S, Cribioli E, Marchand A, Georgeon S, Abken H, Reddy S, Correia BE, Irving M (2024) Drug-controlled CAR-T cells through the regulation of cell-cell interactions. bioRxiv 2024:2008.2006.606454.","journal-title":"bioRxiv"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1158\/2159-8290.CD-23-0101","volume":"13","author":"M Hamieh","year":"2023","unstructured":"Hamieh M, Mansilla-Soto J, Riviere I, Sadelain M (2023) Programming CAR-T cell tumor recognition: tuned antigen sensing and logic gating. Cancer Discov 13:829\u2013843","journal-title":"Cancer Discov"},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cell.2016.01.011","volume":"164","author":"KT Roybal","year":"2016","unstructured":"Roybal KT, Rupp LJ, Morsut L, Walker WJ, McNally KA, Park JS, Lim WA (2016) Precision tumor recognition by T cell combinatorial antigen-sensing circuits. Cell 164:770\u2013779","journal-title":"Cell"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1158\/2326-6066.CIR-21-0307","volume":"10","author":"B Omer","year":"2022","unstructured":"Omer B, Cardenas MG, Pfeiffer T, Daum R, Huynh M, Sharma S, Nouraee N, Xie C, Tat C, Perconti S, Van Pelt S, Scherer L, DeRenzo C, Shum T, Gottschalk S, Arber C, Rooney CM (2022) A costimulatory CAR improves TCR-based cancer immunotherapy. Cancer Immunol Res 10:512\u2013524","journal-title":"Cancer immunology Res"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1089\/hum.2021.173","volume":"32","author":"M Irving","year":"2021","unstructured":"Irving M, Lanitis E, Migliorini D, Ivics Z, Guedan S (2021) Choosing the right tool for genetic engineering: clinical lessons from chimeric antigen receptor-T cells. Hum Gene Ther 32:1044\u20131058","journal-title":"Hum Gene Ther"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"e20211530","DOI":"10.1084\/jem.20211530","volume":"219","author":"SA Oh","year":"2022","unstructured":"Oh SA, Senger K, Madireddi S, Akhmetzyanova I, Ishizuka IE, Tarighat S, Lo JH, Shaw D, Haley B, Rutz S (2022) High-efficiency nonviral CRISPR\/Cas9-mediated gene editing of human T cells using plasmid donor DNA. J Exp Med 219:e20211530","journal-title":"J Exp Med"},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","volume":"543","author":"J Eyquem","year":"2017","unstructured":"Eyquem J, Mansilla-Soto J, Giavridis T, van der Stegen SJ, Hamieh M, Cunanan KM, Odak A, Gonen M, Sadelain M (2017) Targeting a CAR-To the TRAC locus with CRISPR\/Cas9 enhances tumour rejection. Nature 543:113\u2013117","journal-title":"Nature"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551:464\u2013471","journal-title":"Nature"},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/cells9061337","volume":"9","author":"CF Magnani","year":"2020","unstructured":"Magnani CF, Tettamanti S, Alberti G, Pisani I, Biondi A, Serafini M, Gaipa G (2020) Transposon-based CAR-T cell acute leukemias: where are we going? Cell 9:1337","journal-title":"Cell"},{"key":"21_CR21","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41551-023-01013-5","volume":"7","author":"P Reichenbach","year":"2023","unstructured":"Reichenbach P, Giordano Attianese GMP, Ouchen K, Cribioli E, Triboulet M, Ash S, Saillard M, Vuillefroy de Silly R, Coukos G, Irving M (2023) A lentiviral vector for the production of T cells with an inducible transgene and a constitutively expressed tumour-targeting receptor. Nat Biomed Eng 7:1063\u20131080","journal-title":"Nat Biomed Eng"},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","volume":"11","author":"RC Sterner","year":"2021","unstructured":"Sterner RC, Sterner RM (2021) CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J 11:69","journal-title":"Blood Cancer J"},{"key":"21_CR23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s42255-022-00537-5","volume":"4","author":"H Aghajanian","year":"2022","unstructured":"Aghajanian H, Rurik JG, Epstein JA (2022) CAR-based therapies: opportunities for immuno-medicine beyond cancer. Nat Metab 4:163\u2013169","journal-title":"Nat Metab"},{"issue":"11","key":"21_CR24","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41577-024-01035-3","volume":"24","author":"JB Chung","year":"2024","unstructured":"Chung JB, Brudno JN, Borie D, Kochenderfer JN (2024) Chimeric antigen receptor T cell therapy for autoimmune disease. Nat Rev Immunol 24(11):830\u2013845.","journal-title":"Nat Rev Immunol"},{"key":"21_CR25","first-page":"55","volume":"33C","author":"E Lanitis","year":"2015","unstructured":"Lanitis E, Irving M, Coukos G (2015) Targeting the tumor vasculature to enhance T cell activity. Curr Opin Immunol 33C:55\u201363","journal-title":"Curr Opimmunol"},{"key":"21_CR26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ (2011) T cell exhaustion. Nat Immunol 12:492\u2013499","journal-title":"Nat Immunol"},{"key":"21_CR27","doi-asserted-by":"publisher","first-page":"4922","DOI":"10.1038\/s44318-024-00235-w","volume":"43","author":"R Vuillefroy de Silly","year":"2024","unstructured":"Vuillefroy de Silly R, Pericou L, Seijo B, Crespo I, Irving M (2024) Acidity suppresses CD8 + T cell function by perturbing IL-2, mTORC1, and c-Myc signaling. EMBO J 43:4922\u20134953.","journal-title":"EMBO J"},{"key":"21_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/2159-8290.CD-21-0003","volume":"12","author":"FG Herrera","year":"2022","unstructured":"Herrera FG, Ronet C, Ochoa de Olza M, Barras D, Crespo I, Andreatta M, Corria-Osorio J, Spill A, Benedetti F, Genolet R, Orcurto A, Imbimbo M, Ghisoni E, Navarro Rodrigo B, Berthold DR, Sarivalasis A, Zaman K, Duran R, Dromain C, Prior J, Schaefer N, Bourhis J, Dimopoulou G, Tsourti Z, Messemaker M, Smith T, Warren SE, Foukas P, Rusakiewicz S, Pittet MJ, Zimmermann S, Sempoux C, Dafni U, Harari A, Kandalaft LE, Carmona SJ, Dangaj Laniti D, Irving M, Coukos G (2022) Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy. Cancer Discov 12:108\u2013133","journal-title":"Cancer Discov"},{"key":"21_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.copbio.2020.01.009","volume":"65","author":"E Lanitis","year":"2020","unstructured":"Lanitis E, Coukos G, Irving M (2020) All systems go: converging synthetic biology and combinatorial treatment for CAR-T cell therapy. Curr Opin Biotechnol 65:75\u201387","journal-title":"Curr Opin Biotechnol"},{"key":"21_CR30","doi-asserted-by":"publisher","first-page":"976628","DOI":"10.3389\/fimmu.2022.976628","volume":"13","author":"E Cribioli","year":"2022","unstructured":"Cribioli E, Giordano Attianese GMP, Ginefra P, Signorino-Gelo A, Vuillefroy de Silly R, Vannini N, Hess C, Irving M, Coukos G (2022) Enforcing GLUT3 expression in CD8+ T cells improves fitness and tumor control by promoting glucose uptake and energy storage. Front Immunol 13:976628","journal-title":"Front Immunol"},{"key":"21_CR31","doi-asserted-by":"publisher","first-page":"e161660","DOI":"10.1172\/JCI161660","volume":"134","author":"E Stefanidis","year":"2024","unstructured":"Stefanidis E, Semilietof A, Pujol J, Seijo B, Scholten K, Zoete V, Michielin O, Sandaltzopoulos R, Coukos G, Irving M (2024) Combining SiRPalpha decoy-coengineered T cells and antibodies augments macrophage-mediated phagocytosis of tumor cells. J Clin Invest 134:e161660","journal-title":"J Clin Invest"},{"key":"21_CR32","first-page":"2005.2024.54128","volume":"2023","author":"Y Ortiz-Miranda","year":"2023","unstructured":"Ortiz-Miranda Y, Masid M, Jim\u00e9nez-Luna C, Montalvo Bereau GM, Muller T, Rayroux N, Cribioli E, Corr\u00eda-Osorio J, Carrasco Hope H, Vuillefroy de Silly R, Seijo B, Ginefra P, Le\u00f3n K, Vannini N, Ho P-C, Crespo I, Hatzimanikatis V, Irving M, Coukos G (2023) Transcriptional reprogramming by IL-2 variant generates metabolically active stem-like T cells. bioRxiv 2023:2005.2024.541283.","journal-title":"bioRxiv"},{"key":"21_CR33","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41590-023-01477-2","volume":"24","author":"J Corria-Osorio","year":"2023","unstructured":"Corria-Osorio J, Carmona SJ, Stefanidis E, Andreatta M, Ortiz-Miranda Y, Muller T, Rota\u00a0IA, Crespo I, Seijo B, Castro W, Jimenez-Luna C, Scarpellino L, Ronet C, Spill\u00a0A, Lanitis E, Romero P, Luther SA, Irving M, Coukos G (2023) Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8(+) T cells. Nat Immunol 24:869\u2013883","journal-title":"Nat Immunol"},{"key":"21_CR35","doi-asserted-by":"publisher","first-page":"e20192203","DOI":"10.1084\/jem.20192203","volume":"218","author":"E Lanitis","year":"2021","unstructured":"Lanitis E, Rota G, Kosti P, Ronet C, Spill A, Seijo B, Romero P, Dangaj D, Coukos G, Irving M (2021) Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression. J Exp Med 218:e20192203","journal-title":"J Exp Med"},{"key":"21_CR34","first-page":"11","volume":"Chapter 26, Uni","author":"N Drayman","year":"2011","unstructured":"Drayman N, Oppenheim A (2011) Rapid titration of viruses by flow cytometry. Curr Protoc Cell Biol Chapter 26, Unit 26:11.","journal-title":"Curr Protoc Cell Biol"},{"key":"21_CR36","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1158\/2159-8290.CD-20-0896","volume":"11","author":"S Lange","year":"2021","unstructured":"Lange S, Sand LGL, Bell M, Patil SL, Langfitt D, Gottschalk S (2021) A chimeric GM-CSF\/IL18 receptor to sustain CAR-T cell function. Cancer Discov 11:1661\u20131671","journal-title":"Cancer Discov"},{"key":"21_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.omto.2021.06.006","volume":"22","author":"MS Skovgard","year":"2021","unstructured":"Skovgard MS, Hocine HR, Saini JK, Moroz M, Bellis RY, Banerjee S, Morello A, Ponomarev V, Villena-Vargas J, Adusumilli PS (2021) Imaging CAR-T cell kinetics in solid tumors: translational implications. Mol Ther Oncolytics 22:355\u2013367","journal-title":"Mol Ther Oncolytics"},{"key":"21_CR38","doi-asserted-by":"publisher","first-page":"e109427","DOI":"10.1371\/journal.pone.0109427","volume":"9","author":"G Zuccolotto","year":"2014","unstructured":"Zuccolotto G, Fracasso G, Merlo A, Montagner IM, Rondina M, Bobisse S, Figini M, Cingarlini S, Colombatti M, Zanovello P, Rosato A (2014) PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models. PLoS One 9:e109427","journal-title":"PLoS One"}],"container-title":["Methods in Molecular Biology","Antibody Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5041-7_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:40:38Z","timestamp":1778715638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5041-7_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650400","9781071650417"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5041-7_21","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"14 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}